As of the closing on February 24, 166 listed companies on the science and Innovation Board had issued performance forecasts, of which Farasis Energy (Gan Zhou) Co.Ltd(688567) , Cambricon Technologies Corporation Limited(688256) -u are expected to have net losses of up to 1.1 billion yuan and 935 million yuan respectively, which are the “king of advance losses” in the current period. A total of 134 listed companies are expected to have positive net profits in 2021, of which 117 companies are expected to increase over the same period last year.
Among the listed companies that issued performance forecasts, 55 and 8 were newly listed in 2021 and 2022 respectively. Among them, 8 companies have a loss in net profit in advance. Maiwei biology expects a net loss of 782 million yuan at most in 2021, Chengdu Jouav Automation Tech Co.Ltd(688070) from profit to loss.
Another 168 listed companies have issued performance letters. Everdisplay Optronics (Shanghai) Co.Ltd(688538) -u is expected to have a net loss of 947 million yuan. Although the loss is narrower than that in the same period of last year, it is still the enterprise with the highest pre loss.
134 companies reported positive net profit attributable to the parent company, but 17 companies fell year-on-year
According to the performance forecast of each company in 2021, a total of 134 listed companies reported positive net profit attributable to the parent company, of which 117 companies reported an increase over the same period last year. According to the statistics based on the upper limit of net profit, among the 20 companies with the lowest pre profit amount, Verisilicon Microelectronics (Shanghai) Co.Ltd(688521) -u, Shanghai Allist Pharmaceuticals Co.Ltd(688578) -u, Sunshine Guojian Pharmaceutical(Shanghai) Co.Ltd(688336) , xidiwei-u and Bio-Thera Solutions Ltd(688177) -u turned losses into profits.
Figure 1: some listed companies on the science and innovation board with pre earnings in 2021
According to the statistics of the upper limit of net profit, Xinjiang Daqo New Energy Co.Ltd(688303) which is expected to have the highest net profit is expected to have a net profit attributable to the parent company of 580 million yuan in 2021, with a year-on-year increase of more than 4 times Cansino Biologics Inc(688185) -u has turned losses into profits. The expected net profit attributable to the parent company in 2021 is 1.85 billion yuan to 2 billion yuan, a significant increase of more than 2 billion yuan compared with 2020.
Figure 2: 17 Sci-tech Innovation Board companies with pre earnings but declining net profit year-on-year
According to statistics, the net profit of 17 companies on the science and innovation board is expected to be positive, but the year-on-year decline, of which the year-on-year decline of Sinocat Environmental Technology Co.Ltd(688737) and Amethystum Storage Technology Co.Ltd(688086) expected net profit attributable to the parent company is more than 90%. In addition, Guangzhou Fangbang Electronics Co.Ltd(688020) has released the annual report of 2021 on February 17, 2022. The company actually recorded a net profit attributable to the parent company of 378331 million yuan, a year-on-year decrease of 68.27%, which is within the scope of performance forecast.
32 companies with loss forecast Farasis Energy (Gan Zhou) Co.Ltd(688567) , Cambricon Technologies Corporation Limited(688256) as the “king of loss forecast”
According to statistics, a total of 32 listed companies on the science and innovation board are expected to have negative net profit attributable to their parent company in 2021. Among them, according to the statistics of the lower limit of the predicted net loss, Farasis Energy (Gan Zhou) Co.Ltd(688567) and Cambricon Technologies Corporation Limited(688256) -u are expected to have net losses of 1.1 billion yuan and 935 million yuan respectively, which are the “king of predicted losses” of the current period, and the net losses of the two companies are higher than that of the previous year.
Figure 3: Kechuang board company with expected loss in 2021 performance forecast
The total net loss of 15 companies is expected to expand compared with that of 2021. Among them, Beijing Sinohytec Co.Ltd(688339) -u expects a net loss of 140 million yuan to 190 million yuan in 2021, with a net loss of 225236 million yuan in the same period of last year, a year-on-year increase of more than five times.
The expected performance of 12 companies in 2021 is from profit to loss. Among them, the net profit of Sino Medical Sciences Technology Inc(688108) and Bonree Data Technology Co.Ltd(688229) decreased most significantly.
According to the classification of China securities industry, among the 32 listed companies on the sci-tech innovation board that predicted losses in 2021, 9 belong to pharmaceutical manufacturing, and 6 companies in computer, communication and other electronic equipment manufacturing, software and information technology services.
Figure 4: industry distribution of sci tech Innovation Board companies with forecast losses in 2021
63 new shares with 8 losses in advance, Maiwei biological has the largest loss and Chengdu Jouav Automation Tech Co.Ltd(688070) the most significant decline
Among the newly listed companies on the science and innovation board after 2021, 63 issued performance forecasts.
Figure 5: top 30 companies listed on the sci tech innovation board in net profit in 2021 and beyond
Among the companies listed on the science and innovation board in 2021 and beyond, there are 8 companies with negative predicted net profit attributable to the parent in 2021, of which 4 companies belong to the pharmaceutical manufacturing industry. Maiwei biological, which was listed in January 2022, is expected to have a net loss of 782 million yuan at most in 2021, with a year-on-year increase of 21.76%. The losses of Aojie technology-u and Shanghai Yizhong Pharmaceutical Co.Ltd(688091) -u narrowed year-on-year.
Chengdu Jouav Automation Tech Co.Ltd(688070) it is estimated that the net profit attributable to the parent company in 2021 will be – 22 million yuan to – 14 million yuan, from profit to loss. Tianyue advanced-u is expected to turn losses into profits. Its net profit attributable to the parent company in 2021 may be 82 million yuan to 98.4 million yuan, an increase of more than 700 million yuan compared with the same period in 2020.
Among all 63 new shares issued by Kechuang board, Chengdu Jouav Automation Tech Co.Ltd(688070) expects the net profit to decrease by more than 100% year-on-year, with a significant decrease. Dongxin Co., Ltd. is expected to realize a net profit attributable to its parent company of 245 million yuan to 275 million yuan in 2021, with a year-on-year increase of more than 10 times. In addition, the year-on-year growth rate of the estimated net profit of Novogene Co.Ltd(688315) and Xinjiang Daqo New Energy Co.Ltd(688303) may exceed 4 times.
168 companies release performance express Everdisplay Optronics (Shanghai) Co.Ltd(688538) maximum loss in advance
According to statistics, as of the closing on February 24, a total of 168 listed companies on the science and Innovation Board issued performance letters.
Figure 6: pre loss listed companies on the science and innovation board that released the 2021 performance express
Among the above companies that issued the performance express, Everdisplay Optronics (Shanghai) Co.Ltd(688538) -u is expected to have a net loss of 947 million yuan, which is slightly narrower than that in the same period of last year Sinocelltech Group Limited(688520) estimated net loss is 867 million yuan, which is within the range of “850 million yuan to 880 million yuan” previously predicted. The remaining more than 160 Sci-tech Innovation Board companies recorded positive net profit attributable to the parent company.
